美股A股
StockGist
Back
6-K2026-04-29· qwen-plus

SNDL · SNDL Inc.

0001171843-26-002797

SEC filing

Summary

SNDL Inc. reported first quarter 2026 net revenue of $195.9 million (CAD), down 4.4% year-over-year, with gross margin at 27.0%, operating loss of $(9.1) million, and negative free cash flow of $(7.6) million, while maintaining $213.4 million in unrestricted cash and no debt as of March 31, 2026.

Key takeaways

Full analysis

SNDL’s Q1 2026 results reflect persistent market softness across both core businesses: Liquor Retail net revenue declined 4.9% year-over-year, driven by a -6.1% same-store sales drop, while Cannabis Operations revenue fell 14.2% due to destocking, order phasing delays, and lower production volumes — resulting in a sharp 7.1 percentage point gross margin contraction to 19.7%. Although Cannabis Retail revenue held relatively flat (-0.3%), its operating income declined 15.9% due to $1 million in unadjusted one-time charges, even as gross margin expanded 1.0 pp on pricing and mix improvements. The consolidated operating loss improved to $(9.1) million, not from top-line strength but from the absence of prior-year equity-investee valuation write-downs and restructuring costs — underscoring that profitability gains remain structural rather than organic. Free cash flow turned negative at $(7.6) million, reflecting both income statement losses and inventory accumulation in Cannabis Operations, signaling working capital inefficiency. Management explicitly cited 'market softness' and 'challenging conditions' — with no forward guidance issued — while highlighting proactive measures: Jeeter brand launch, $20 million profit-enhancement initiatives, SunStream restructuring progress, and continued share repurchases. With $213.4 million in unrestricted cash and zero debt, SNDL retains significant financial flexibility, but near-term execution risk remains elevated given segment-level margin erosion and lack of revenue recovery signals. The DOJ/DEA’s April 23, 2026 cannabis rescheduling announcement is noted as a positive long-term catalyst for U.S. exposure, though timing and impact remain uncertain.